A Skp2 autoinduction loop and restriction point control

Journal of Cell Biology

Volumn 178, Issue 5, 2007, Pages 741-747

  Yung, Yuval ^a   Walker, Janice L ^a   Roberts, James M ^b   Assoian, Richard K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P27; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEEDBACK, BIOCHEMICAL; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; PAPILLOMAVIRUS E7 PROTEINS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; S PHASE; S-PHASE KINASE-ASSOCIATED PROTEINS;

HUMAN PAPILLOMAVIRUS;

EID: 34548356374     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200703034     Document Type: Article

References (37)

1. Bashir, T., N.V. Dorrello, V. Amador, D. Guardavaccaro, and M. Pagano. 2004. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature. 428:190-193.
2. Binne, U.K., M.K. Classon, F.A. Dick, W. Wei, M. Rape, W.G. Kaelin Jr., A.M. Naar, and N.J. Dyson. 2007. Retinoblastoma protein and anaphasepromoting complex physically interact and functionally cooperate during cell-cycle exit. Nat. Cell Biol. 9:225-232.
3. Blagosklonny, M.V., and A.B. Pardee. 2002. The restriction point of the cell cycle. Cell Cycle. 1:103-110.
4. Bottazzi, M.E., X. Zhu, R.M. Bohmer, and R.K. Assoian. 1999. Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell Biol. 146:1255-1264.
5. Carrano, A.C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199.
6. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
7. Dou, Q.P., A.H. Levin, S. Zhao, and A.B. Pardee. 1993. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 53:1493-1497.
8. Gstaiger, M., R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek. 2001. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA. 98:5043-5048.
9. Hsu, J.Y., J.D. Reimann, C.S. Sorensen, J. Lukas, and P.K. Jackson. 2002. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nat. Cell Biol. 4:358-366.
10. Imaki, H., K. Nakayama, S. Delehouzee, H. Handa, M. Kitagawa, T. Kamura, and K.I. Nakayama. 2003. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res. 63:4607-4613.
11. Izumi, M., M. Yokoi, N.S. Nishikawa, H. Miyazawa, A. Sugino, M. Yamagishi, M. Yamaguchi, A. Matsukage, F. Yatagai, and F. Hanaoka. 2000. Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase alpha is controlled by E2F, an Ets-related transcription factor, and Sp1. Biochim. Biophys. Acta. 1492:341-352.
12. Ji, P., H. Jiang, K. Rekhtman, J. Bloom, M. Ichetovkin, M. Pagano, and L. Zhu. 2004. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell. 16:47-58.
13. Kamata, Y., J. Watanabe, Y. Nishimura, T. Arai, M. Kawaguchi, M. Hattori, A. Obokata, and H. Kuramoto. 2005. High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma. J. Cancer Res. Clin. Oncol. 131:591-596.
14. Klein, E.A., Y. Yung, P. Castagnino, D. Kothapalli, and R.K. Assoian. 2007. Cell adhesion, cellular tension and cell cycle control. Methods Enzymol. In press.
15. Kothapalli, D., S.A. Stewart, E.M. Smyth, I. Azonobi, E. Pure, and R.K. Assoian. 2003. Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin a gene expression. Mol. Pharmacol. 64:249-258.
16. Malek, N.P., H. Sundberg, S. McGrew, K. Nakayama, T.R. Kyriakides, and J.M. Roberts. 2001. A mouse knockin model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature. 413:323-327.
17. Markey, M.P., S.P. Angus, M.W. Strobeck, S.L. Williams, R.W. Gunawardena, B.J. Aronow, and E.S. Knudsen. 2002. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res. 62:6587-6597.
18. Marti, A., C. Wirbelauer, M. Scheffner, and W. Krek. 1999. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1:14-19.
19. Nakayama, K.I., and K. Nakayama. 2005. Regulation of the cell cycle by SCFtype ubiquitin ligases. Semin. Cell Dev. Biol. 16:323-333.
20. Neuman, E., E.K. Flemington, W.R. Sellers, and W.G. Kaelin Jr. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14:6607-6615.
21. Ohtani, K., J. DeGregori, and J. Nevin. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:12146-12150.
22. Polyak, K., M.H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:59-66.
23. Reed, S.I. 2003. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat. Rev. Mol. Cell Biol. 4:855-864.
24. Rodier, G., C. Makris, P. Coulombe, A. Scime, K. Nakayama, K.I. Nakayama, and S. Meloche. 2005. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J. Cell Biol. 168:55-66.
25. Stewart, S.A., D. Kothapalli, Y. Yung, and R.K. Assoian. 2004. Antimitogenesis linked to regulation of Skp2 gene expression. J. Biol. Chem. 279:29109-29113.
26. Sutterluty, H., E. Chatelain, A. Marti, C. Wirbelauer, M. Senften, U. Muller, and W. Krek. 1999. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207-214.
27. Tao, Y., R.F. Kassatly, W.D. Cress, and J.M. Horowitz. 1997. Subunit composition determines E2F DNA-binding site specificity. Mol. Cell. Biol. 17:6994-7007.
28. Timmerbeul, I., C.M. Garrett-Engele, U. Kossatz, X. Chen, E. Firpo, V. Grunwald, K. Kamino, L. Wilkens, U. Lehmann, J. Buer, et al. 2006. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Proc. Natl. Acad. Sci. USA. 103:14009-14014.
29. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:67-74.
30. Tsvetkov, L.M., K.H. Yeh, S.J. Lee, H. Sun, and H. Zhang. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661-664.
31. Vernell, R., K. Helin, and H. Muller. 2003. Identification of target genes of the p16INK4A-pRB-E2F pathway. J. Biol. Chem. 278:46124-46137.
32. Walker, J.L., P. Castagnino, B.M. Chung, M.G. Kazanietz, and R.K. Assoian. 2006. Post-transcriptional destabilization of p21cip1 by protein kinase C in fibroblasts. J. Biol. Chem. 50:38127-38132.
33. Wei, W., N.G. Ayad, Y. Wan, G.J. Zhang, M.W. Kirschner, and W.G. Kaelin Jr. 2004. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature. 428:194-198.
34. Welsh, C.F., K. Roovers, J. Villanueva, Y. Liu, M.A. Schwartz, and R.K. Assoian. 2001. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat. Cell Biol. 3:950-957.
35. Zhang, H., R. Kobayashi, K. Galaktionov, and D. Beach. 1995. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 82:915-925.
36. Zhang, L., and C. Wang. 2006. F-box protein Skp2: a novel transcriptional target of E2F. Oncogene. 25:2615-2627.
37. Zheng, W.Q., J.M. Zheng, R. Ma, F.F. Meng, and C.R. Ni. 2005. Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy. Steroids. 70:770-774.